XML 200 R69.htm IDEA: XBRL DOCUMENT v3.7.0.1
Significant equity transactions, restructuring transactions, mergers and acquisitions and equity investments- Alibaba Health (Details)
HKD in Millions, $ in Millions, shares in Billions
1 Months Ended 12 Months Ended
May 31, 2017
HKD
shares
Apr. 30, 2016
CNY (¥)
Jul. 31, 2015
CNY (¥)
Apr. 30, 2014
HKD
Apr. 30, 2014
CNY (¥)
Mar. 31, 2017
CNY (¥)
Mar. 31, 2016
CNY (¥)
Mar. 31, 2017
USD ($)
Mar. 31, 2017
CNY (¥)
Jul. 31, 2015
HKD
Jul. 31, 2015
CNY (¥)
Mar. 31, 2015
CNY (¥)
Acquisition                        
Issuance of ordinary shares           ¥ 11,189,000,000            
The allocation of the equity value at the date of the deemed acquisition                        
Goodwill             ¥ 81,645,000,000 $ 18,221 ¥ 125,420,000,000     ¥ 41,933,000,000
The equity value comprised of:                        
- fair value of previously held equity interests   ¥ 6,376,000,000                    
Developed technology and patents | Maximum                        
The equity value comprised of:                        
Estimated amortization periods           5 years            
Trade names, trademarks and domain names | Maximum                        
The equity value comprised of:                        
Estimated amortization periods           20 years            
User base and customer relationships | Maximum                        
The equity value comprised of:                        
Estimated amortization periods           6 years            
Alibaba Health                        
Acquisition                        
Equity interest held (as a percentage)                   54.00% 54.00%  
Equity interest held in subsidiary (as a percentage)                   38.00% 38.00%  
Equity value                   HKD 64,319 ¥ 50,723,000,000  
Gain recognized in relation to the revaluation of previously held equity interest relating to obtaining control             ¥ 18,603,000,000          
The allocation of the equity value at the date of the deemed acquisition                        
Net assets acquired                     1,290,000,000  
Goodwill                     49,320,000,000  
Deferred tax assets                     19,000,000  
Deferred tax liabilities                     (19,000,000)  
Total                   HKD 64,319 50,723,000,000  
The equity value comprised of:                        
- fair value of previously held equity interests     ¥ 19,264,000,000                  
- fair value of noncontrolling interests     31,459,000,000                  
Total     ¥ 50,723,000,000                  
Weighted average amortization period     2 years 7 months 6 days                  
Alibaba Health | Future                        
Acquisition                        
Issuance of ordinary shares | HKD HKD 3,800                      
Issuance of ordinary shares (in shares) | shares 1.2                      
Equity interest held in subsidiary (as a percentage) 46.00%                      
Alibaba Health | Maximum                        
The equity value comprised of:                        
Estimated amortization periods     3 years                  
Alibaba Health | Developed technology and patents                        
The allocation of the equity value at the date of the deemed acquisition                        
Amortizable intangible assets                     70,000,000  
Alibaba Health | Trade names, trademarks and domain names                        
The allocation of the equity value at the date of the deemed acquisition                        
Amortizable intangible assets                     35,000,000  
Alibaba Health | User base and customer relationships                        
The allocation of the equity value at the date of the deemed acquisition                        
Amortizable intangible assets                     ¥ 8,000,000  
Special purpose entity | Ordinary Shares                        
Acquisition                        
Equity interest (as a percent)       70.00% 70.00%              
Alibaba Health | Yunfeng                        
Acquisition                        
Consideration paid to related party for giving up its voting rights with respect to its indirect interest in investee     ¥ 0                  
Alibaba Health | Ordinary Shares                        
Acquisition                        
Equity interest (as a percent)       38.00% 38.00%              
Purchase consideration, equity method       HKD 932 ¥ 741,000,000              
Company and Yunfeng | Alibaba Health | Ordinary Shares                        
Acquisition                        
Percentage of equity interest acquired       54.00% 54.00%              
Yunfeng | Special purpose entity | Ordinary Shares                        
Acquisition                        
Equity interest (as a percent)       30.00% 30.00%